Table 1.
References | Group | Recanalization | mRS, 0–2 | Symptomatic ICH | Mortality |
---|---|---|---|---|---|
Kang et al. (8) | ICAS-related | 80.0% | 65.0% | 2.5% | NA |
Embolic | 83.7% | 67.5% | 5.4% | NA | |
Lee et al. (16) | ICAS-related | 62.5% | 41.7% | NA | 8.3% |
Embolic | 63.6% | 31.3% | NA | 24.6% | |
Jia et al. (18) | ICAS-related | 95.7% | 63.8% | 4.3% | 12.8% |
Embolic | 96.8% | 51.6% | 4.3% | 12.9% | |
Al Kasab et al. (17) | ICAS-related | *64.7% | *42.4% | 11.1% | 39.4% |
Embolic | *95.3% | *55.8% | 9.8% | 20.7% | |
Yoon et al. (15) | ICAS-related | *95.0% | *62.5% | 7.5% | 15.0% |
Embolic | *81.8% | *38.6% | 3.0% | 9.1% | |
Baek et al. (14) | ICAS-related | 80.4% | 46.4% | 5.4% | 19.6% |
Embolic | 88.5% | 46.9% | 5.0% | 15.3% | |
Lee et al. (19) | ICAS-related | 76.8% | 45.5% | 7.1 | NA |
Embolic | 79.6% | 54.5% | 10.7 | NA |
ICAS, intracranial atherosclerotic stenosis; mRS, modified Rankin Scale score; ICH, intracranial hemorrhage;
, statistically significant.